-
Share
221 Posts.
3
13/12/17
07:22
Share
All management PR.
Bell Potter want the next capital raise.
Edison get money for saying those things.
And Bioshares hardly ever says anything negative about biotech.
Also, they have been saying the same things for 3 years with similar valuations.
The board and managers think doing this is worthwhile rather than selling the company for the shareholders benefit.
As the US based funds work out that these guys can't/won;t do a deal, they will dump the stock.
Dumb, dumb, dumb.
-